Results 41 to 50 of about 8,790,513 (336)

Cost Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms

American Journal of Gastroenterology, 2020
Objective: The value of hepatocellular carcinoma (HCC) surveillance is defined by the balance of benefits, i.e. early tumor detection, and potential harms, related to false positive and indeterminate results. Although physical harms can be observed in 15–
N. Parikh, A. Singal, D. Hutton, E. Tapper   +3 more
semanticscholar   +1 more source

The cost-effectiveness of exercise referral schemes [PDF]

, 2011
This article is made available through the Brunel Open Access Publishing Fund - Copyright @ 2011 Anokye et al.Background: Exercise referral schemes (ERS) aim to identify inactive adults in the primary care setting.
Paul Trueman, Hillsdon, M, Nana K Anokye, Anokye, Nana K, Pavey, TG, Green, C, Colin Green, Pavey, Toby G, Anokye, Nana K., Taylor, RS, Green, Colin, Hillsdon Melvyn, Taylor, Rod S., Melvyn Hillsdon, Pavey, Toby G., Trueman, P, Toby G Pavey, Anokye Nana K, Green Colin, Anokye, NK, Trueman Paul, Trueman, Paul, Rod S Taylor, Pavey Toby G, Hillsdon, Melvyn, Taylor Rod S   +25 more
core   +3 more sources

Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold

ClinicoEconomics and Outcomes Research, 2015
In health technology assessment (HTA) agencies where cost-effectiveness plays a role in decision-making, an incremental cost-effectiveness ratio (ICER) threshold is often used to inform reimbursement decisions. The acceptance of submissions with ICERs higher than the threshold was assessed across different agencies and across indications, in order to ...
Griffiths,Elizabeth, Hendrich,Janek, Stoddart,Samuel, Walsh,Sean   +3 more
openaire   +6 more sources

How to assess the value of medicines?

Frontiers in Pharmacology, 2010
This study aims to discuss approaches to assessing the value of medicines. Economic evaluation assesses value by means of the incremental cost-effectiveness ratio (ICER).
Steven Simoens
doaj   +1 more source

The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK

Journal of Market Access & Health Policy
Background: Thrombopoietin receptor agonists—romiplostim, eltrombopag and avatrombopag—are commonly used as second-line treatments for immune thrombocytopenia (ITP).
Nichola Cooper, Sebastian Guterres, Michał Pochopień, Koo Wilson, Sam James, Mondher Toumi, Anna Tytuła, Carly Rich, Daniel Eriksson   +8 more
doaj   +1 more source

Cost-effectiveness of the Perioperative Pain Management Bundle a registry-based study

Frontiers in Public Health, 2023
IntroductionThe Perioperative Pain Management Bundle was introduced in 10 Serbian PAIN OUT network hospitals to improve the quality of postoperative pain management. The Bundle consists of 4 elements: informing patients about postoperative pain treatment
Suzana Bojic, Suzana Bojic, Nebojsa Ladjevic, Nebojsa Ladjevic, Ivan Palibrk, Ivan Palibrk, Ivan Soldatovic, Ivana Likic-Ladjevic, Ivana Likic-Ladjevic, Winfried Meissner, Ruth Zaslansky, Ulrike M Stamer, Philipp Baumbach, Dusica Stamenkovic, Dusica Stamenkovic   +14 more
doaj   +1 more source

Applying the net-benefit framework for assessing cost-effectiveness of interventions towards universal health coverage

Cost Effectiveness and Resource Allocation, 2012
In assessing the cost-effectiveness of an intervention, the interpretation and handling of uncertainties of the traditional summary measure, the Incremental Cost Effectiveness Ratio (ICER), can be problematic.
Hounton Sennen, Newlands David
doaj   +1 more source

Total cost, cases detected, incremental costs, incremental cases detected and incremental cost effectiveness ratio (ICER).

, 2015
Total cost, cases detected, incremental costs, incremental cases detected and incremental cost effectiveness ratio (ICER).
Richard E. Nelson (764526), Brian R. Jackson (233567), Edward R. Ashwood (764528), David G. Grenache (764527), Brandon S. Walker (764525), Robert L. Schmidt (764529)   +5 more
core   +1 more source

Tornado diagram shows incremental cost-effectiveness ratio (ICER) of anlotinib vs. sunitinib for different input parameters.

, 2023
Tornado diagram shows incremental cost-effectiveness ratio (ICER) of anlotinib vs. sunitinib for different input parameters.
Qingxia Fang (14581136), Xiaochun Zheng (8562900), Jingyang Lin (12041165)   +2 more
core   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo, Weisi Dai, Jie Mao, Mei Ye, Xingshan Lu, Xiaocui Zhang   +5 more
wiley   +1 more source